Back to search
Cardiac Congenital Defects
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiac Congenital Defects trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiac Congenital Defects trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
VT-10201 is an Open-label, Phase 1b, Single-ascending Dose Study That Will Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial…
Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque-like subst…
The overall short-term goals of this project include the following: 1) identify the genes that are key to the function of respiratory cilia to protect the norma…
Approximately 1.5 million of the 44 million Blacks in the United States are carriers of the valine-to-isoleucine substitution at position 122 (V122I) in the tra…
This is a Phase 1 study to determine the safety and efficacy of allogeneic neonatal mesenchymal stromal cells (nMSCs) for the treatment of Dilated Cardiomyopath…
SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility stu…
Unrecognized coarctation of the aorta (CoA) is a life-threatening component of congenital heart disease (CHD) in which narrowing of the aorta causes obstructed…
The primary objective of this study is to define the intracardiac flow imaging biomarkers in cardiac amyloidosis.